Related Experiment Video
Updated: May 2, 2026

Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin
Published on: July 14, 2017
iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function
Matthew A Brooke1, Sarah L Etheridge1, Nihal Kaplan2
1Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Abstract:
iRHOM2 is a highly conserved, catalytically inactive member of the Rhomboid family, which has recently been shown to regulate the maturation of the multi-substrate ectodomain sheddase enzyme ADAM17 (TACE) in macrophages. Dominant iRHOM2 mutations are the cause of the inherited cutaneous and oesophageal cancer-susceptibility syndrome tylosis with oesophageal cancer (TOC), suggesting a role for this protein in epithelial cells. Here, using tissues derived from TOC patients, we demonstrate that TOC-associated mutations in iRHOM2 cause an increase in the maturation and activity of ADAM17 in epidermal keratinocytes, resulting in significantly upregulated shedding of ADAM17 substrates, including EGF-family growth factors and pro-inflammatory cytokines. This activity is accompanied by increased EGFR activity, increased desmosome processing and the presence of immature epidermal desmosomes, upregulated epidermal transglutaminase activity and heightened resistance to Staphylococcal infection in TOC keratinocytes. Many of these features are consistent with the presence of a constitutive wound-healing-like phenotype in TOC epidermis, which may shed light on a novel pathway in skin repair, regeneration and inflammation.
Insights
Mutations in iRHOM2 protein increase ADAM17 activity in skin cells, leading to elevated growth factor shedding and a wound-healing-like phenotype. This discovery offers new insights into skin repair and inflammation pathways.
Area of Science:
- Cell Biology
- Dermatology
- Genetics
Background:
- iRHOM2, a catalytically inactive Rhomboid family member, regulates ADAM17 (TACE) maturation in macrophages.
- Dominant iRHOM2 mutations cause tylosis with oesophageal cancer (TOC), a cancer-susceptibility syndrome, indicating a role in epithelial cells.
Purpose of the Study:
- To investigate the function of iRHOM2 mutations in epithelial cells, specifically in the context of TOC.
- To elucidate the molecular mechanisms linking iRHOM2 mutations to cancer susceptibility and skin phenotypes.
Main Methods:
- Analysis of tissues from TOC patients.
- Assessment of ADAM17 maturation and activity in epidermal keratinocytes.
- Evaluation of ADAM17 substrate shedding, EGFR activity, desmosome processing, and transglutaminase activity.
Main Results:
- TOC-associated iRHOM2 mutations increase ADAM17 maturation and activity in epidermal keratinocytes.
- Upregulated shedding of ADAM17 substrates, including EGF-family growth factors and pro-inflammatory cytokines, was observed.
- Increased EGFR activity, altered desmosome processing, heightened transglutaminase activity, and enhanced resistance to Staphylococcal infection were noted in TOC keratinocytes.
Conclusions:
- iRHOM2 mutations promote a constitutive wound-healing-like phenotype in the epidermis.
- This study reveals a novel pathway involving iRHOM2, ADAM17, and epidermal homeostasis, with implications for skin repair, regeneration, and inflammation.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Adherens Junctions
Adherens Junctions are Dynamic
Desmosomes
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

